---
title: "H.C. Wainwright Sticks to Their Buy Rating for LB Pharmaceuticals, Inc. (LBRX)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289088253.md"
description: "H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on LB Pharmaceuticals (LBRX) with a $45 price target. The broader analyst consensus for LBRX is Strong Buy, with an average price target of $46.83."
datetime: "2026-06-08T17:35:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289088253.md)
  - [en](https://longbridge.com/en/news/289088253.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289088253.md)
generator: "portal-rs"
---

# H.C. Wainwright Sticks to Their Buy Rating for LB Pharmaceuticals, Inc. (LBRX)

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on LB Pharmaceuticals, Inc., with a price target of $45.00.

### Introducing TipRanks MCP for Agents

-   Deliver institutional-grade market data directly into Claude, ChatGPT, Cursor, and other MCP-compatible AI tools.
-   Designed for personal research, portfolio monitoring, and AI-assisted investment workflows.

Selvaraju covers the Healthcare sector, focusing on stocks such as Emergent Biosolutions, Aclaris Therapeutics, and Urogen Pharma. According to TipRanks, Selvaraju has an average return of 18.4% and a 50.10% success rate on recommended stocks. 

Currently, the analyst consensus on LB Pharmaceuticals, Inc. is a Strong Buy with an average price target of $46.83.

### Related Stocks

- [LBRX.US](https://longbridge.com/en/quote/LBRX.US.md)
- [EBS.US](https://longbridge.com/en/quote/EBS.US.md)
- [ACRS.US](https://longbridge.com/en/quote/ACRS.US.md)
- [URGN.US](https://longbridge.com/en/quote/URGN.US.md)

## Related News & Research

- [LB Pharma to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297953050.md)
- [AI agents keep finding ways to bend the rules. Here are some of the wildest.](https://longbridge.com/en/news/298138114.md)
- [Sonos opens platform to connect with outside AI assistants including ChatGPT, Claude via MCP](https://longbridge.com/en/news/298335937.md)
- [Journey Medical CEO Maraoui to present at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/298359762.md)
- [YieldMax® AI & Tech Portfolio Option Income ETF declares $0.2888 dividend](https://longbridge.com/en/news/298334201.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**